Jun Zhao1,2, Jialiang Chen1,3, Wenbin Guo1,4, Katherine Shapiro1, Anand Mohapatra1, Yihua Zhong1,5, Kody Armann1, Bing Shen1, Jicheng Wang1, Jonathan Beckel6, William C de Groat6, Changfeng Tai1,6,7. 1. Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania. 2. Department of Urology, The Second Affiliated Hospital of Xian Jiaotong University, Xian, China. 3. Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 4. Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. 5. School of Biomedical Engineering, Capital Medical University, Beijing, China. 6. Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania. 7. Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
AIMS: To determine if superficial peroneal nerve stimulation (SPNS) can improve nonobstructive urinary retention (NOUR). METHODS: In α-chloralose anesthetized cats, NOUR was induced by repetitive application (4-16 times) of 30-minute tibial nerve stimulation (TNS: 5 Hz frequency, 0.2 ms pulse width) at 4 to 6 times threshold intensity (T) for inducing toe twitches. SPNS (1 Hz, 0.2 ms) at 2 to 4 times threshold intensity (T) for inducing posterior thigh muscle contractions was applied either continuously (SPNSc) during a cystometrogram (CMG) or during voiding (SPNSv) by a surgically implanted cuff electrode or by skin surface electrodes to determine if the stimulation reduced NOUR induced by prolonged TNS. RESULTS: During control CMGs, efficient (86.4% ± 5.5%) voiding occurred with a postvoid residual (PVR) volume equal to 14.9% ± 6.2% of control bladder capacity. NOUR elicited by prolonged TNS significantly (P < .05) increased bladder capacity to 168.6% ± 15.5% of control, reduced voiding efficiency to 30.4% ± 4.8%, and increased PVR to 109% ± 9.2% of control. Using the implanted cuff electrode, SPNSc and SPNSv significantly (P < .05) increased voiding efficiency to 66.7% ± 7.4% and 65.0% ± 5.9%, respectively, and reduced PVR to 52.2% ± 11.4% and 64.3% ± 11.6%, respectively. SPNSc but not SPNSv significantly (P < .05) reduced bladder capacity to 133.4% ± 15% of control. Transcutaneous SPNSv but not SPNSc also significantly (P < .05) reversed the TNS-induced NOUR responses. CONCLUSIONS: This study shows that SPNS is effective in reversing NOUR induced by prolonged TNS. Transcutaneous SPNS provides the opportunity to develop a noninvasive neuromodulation therapy for NOUR to treat more patients than current sacral neuromodulation therapy.
AIMS: To determine if superficial peroneal nerve stimulation (SPNS) can improve nonobstructive urinary retention (NOUR). METHODS: In α-chloralose anesthetized cats, NOUR was induced by repetitive application (4-16 times) of 30-minute tibial nerve stimulation (TNS: 5 Hz frequency, 0.2 ms pulse width) at 4 to 6 times threshold intensity (T) for inducing toe twitches. SPNS (1 Hz, 0.2 ms) at 2 to 4 times threshold intensity (T) for inducing posterior thigh muscle contractions was applied either continuously (SPNSc) during a cystometrogram (CMG) or during voiding (SPNSv) by a surgically implanted cuff electrode or by skin surface electrodes to determine if the stimulation reduced NOUR induced by prolonged TNS. RESULTS: During control CMGs, efficient (86.4% ± 5.5%) voiding occurred with a postvoid residual (PVR) volume equal to 14.9% ± 6.2% of control bladder capacity. NOUR elicited by prolonged TNS significantly (P < .05) increased bladder capacity to 168.6% ± 15.5% of control, reduced voiding efficiency to 30.4% ± 4.8%, and increased PVR to 109% ± 9.2% of control. Using the implanted cuff electrode, SPNSc and SPNSv significantly (P < .05) increased voiding efficiency to 66.7% ± 7.4% and 65.0% ± 5.9%, respectively, and reduced PVR to 52.2% ± 11.4% and 64.3% ± 11.6%, respectively. SPNSc but not SPNSv significantly (P < .05) reduced bladder capacity to 133.4% ± 15% of control. Transcutaneous SPNSv but not SPNSc also significantly (P < .05) reversed the TNS-induced NOUR responses. CONCLUSIONS: This study shows that SPNS is effective in reversing NOUR induced by prolonged TNS. Transcutaneous SPNS provides the opportunity to develop a noninvasive neuromodulation therapy for NOUR to treat more patients than current sacral neuromodulation therapy.
Authors: Alan D Uren; Nikki Cotterill; Christopher Harding; Christopher Hillary; Christopher Chapple; Monique Klaver; Dominique Bongaerts; Zalmai Hakimi; Paul Abrams Journal: Eur Urol Date: 2017-04-08 Impact factor: 20.096
Authors: Michael B Chancellor; Sarah N Bartolone; Elise M DeVries; Ananias C Diokno; Mark Gibbons; Ronald Jankowski; Laura E Lamb; Ryan Pruchnic; Karl Thor; Roger Dmochowski Journal: Neurourol Urodyn Date: 2018-06-28 Impact factor: 2.696
Authors: Michelle Yu; Jamie Uy; Xuewen Jiang; Xing Li; Cameron Jones; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai Journal: Am J Physiol Renal Physiol Date: 2017-08-30
Authors: U Jonas; C J Fowler; M B Chancellor; M M Elhilali; M Fall; J B Gajewski; V Grünewald; M M Hassouna; U Hombergh; R Janknegt; P E van Kerrebroeck; A A Lylcklama a Nijeholt; S W Siegel; R A Schmidt Journal: J Urol Date: 2001-01 Impact factor: 7.450
Authors: Katherine Theisen; Jeffery Browning; Xing Li; Shun Li; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai Journal: Neuromodulation Date: 2018-06-27